The effect op corticosteroids on quality of life following total hip arthroplasty: HIPSTER study
EU CTIS ID: 2025-524368-39-00
What this study is testing
To evaluate the effect of different doses of a single intraoperative dose of dexamethasone (5 mg versus 25 mg) on health-related quality of life up to three months after surgery
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- aged 60 years or older
- scheduled for elective total hip arthroplasty
- procedure under spinal anaesthesia
You likely can't join if
- hip revision surgery (reoperation)
- bilateral total hip arthroplasty during the same procedure
- chronic systemic use of corticosteroids, defined as daily corticosteroid therapy for > 4 weeks within the last 3 months, with anticipated need for a perioperative stress dose of corticosteroids
- lack of informed consent or inability to give informed consent
- urgent, non-elective surgery
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.